Pancreatic cancer is one of the most aggressive malignancies nowadays. 1 It accounts for 3% of new cases per annum, 2 and it is fourth leading cause of deaths in the west due to malignancy. Pancreatic cancer has a poor prognosis with 5 years survival <5%, 3 despite active surgical treatment. With newer modalities of treat-ment, outcomes of pancreatic cancer still remain poor and has changed very little in the last three decades. Surgery is the mainstay of treatment; but adjuvant chemotherapy is essential for long term survival. Risk factors for pancreatic cancer are smoking, 4 alcohol, chronic pancreatitis and diabetes mellitus, 5 however exact cause remains unknown.
INTRODUCTION
intra-abdominal collection, bleeding and pulmonary complications. 9 With recent advance-ment in perioperative care, mortality rates after pancreatic resection have been reduced to less than 5%. 10 After surgical resection, the treatment failure is mainly due to metastasis and local recurrence. Postoperative morbidity remains as high as 30-50% even in high volume centres different techniques are used in these cases. 11 Postoperative pancreatic fistula (POPF) is the major cause of postoperative morbidity and its incidence is 9% to 29%. 12 POPF significantly affects the patient's quality of life and also increases the treatment cost. Hospital stay is prolonged and postoperative mortality is also increased. 13 To reduce the incidence of POPF, different techniques were used for pancreatico-enteric anastomosis. Most commonly used techniques are pancreaticogastrostomy (PG) and pancreaticojejunostomy (PJ). Although some studies favour PG over PJ, but there is no consensus about the best technique. [14] [15] [16] The rationale of this study was to share an evidence-based experience of pancreaticoduodenectomy in these cases.
The objective of the study was to determine the safety of pancreaticogastrostomy in pancreaticoduodenectomy in patients with periampullary and pancreatic head neoplasms in terms of surgical technique, pancreatic fistula rate, 30 days mortality and three years survival. In all patients, cytological or histological diagnoses of malignancy were confirmed by means of endoscopic biopsy, biliary brush cytology or endoscopic ultrasound, guided FNAC. Computed tomography (CT) scan and endoscopic ultrasound were performed in all patients for preoperative staging of the disease. All patients were discussed in multidisciplinary team meeting before starting any treatment.
METHODOLOGY
Standard pancreaticoduodenectomy(PD) (Resection of distal stomach, duodenum, pancreatic head, gall bladder and CBD) was performed in all patients. For reconstruction pancreaticojejunostomy (PJ) and pancreaticogastrostomy (PG) techniques were used. In PG reconstruction, an opening was made in the posterior wall of stomach and pancreatic stump was invaginated into the stomach. This end-to-side pancreaticogastrostomy was secured with non-absorbable interrupted sutures. For PJ reconstruction, a two layered end-to-side anastomosis was designed with interrupted non-absorbable sutures. A stent in the pancreatic duct was placed when the duct was dilated and could accommodate at least a 5-6 Fr. feeding tube. After PG or PJ reconstruction, end-to-side hepaticojejunostomy was performed followed by gastrojejunostomy and entero-enterostomy. Two abdominal drains were placed in every patient. Nasogastric and nasojejunal tubes were inserted after surgery.
On the first postoperative day, oral sips of water was started and nasogastric tube was removed. Amylase levels of drain fluids were checked on third postoperative day. If amylase levels were found to be normal then oral free fluids were started and progressed to soft diet. When patient's postoperative pain was controlled on oral analgesia and they had started taking solid diet then they were discharged from the hospital.
Postoperative complications, needing surgical or medical treatment, were recorded; especially postoperative pancreatic fistula (POPF). Perioperative mortality was defined as any death, regardless of the cause, occurring in the same admission or within 30 days of surgery. All patients were operated by the same surgeon (FH).
POPF was classified and defined according to International Study Group of Pancreatic Fistula (ISGPF) classification. It was defined as if drain fluid amylase levels were more than three times of upper normal serum value after the third postoperative day. 17 According to ISGPF, POPF was classified into three grades of severity.
Grade A pancreatic fistula (biochemical leak) was considered when there was no peripancreatic collection on imaging and patient was clinically well, but there is delayed removal of abdominal drains. Postoperative management was not changed in these cases.
Grade B pancreatic fistula was considered when patient was doing well clinically, but needed some special measures like placement or repositioning of peripancreatic drains leading to prolonged hospital stay. Patients were discharged with drains and followed up as outpatient.
Grade C pancreatic fistula was labelled when patient was unwell clinically and medical or surgical intervention was required. Major change was required in management plan including prolonged hospital stay, intensive care support and increased chances of mortality.
Initially, adjuvant chemotherapy was given according to ESPAC-3 trial, 18 which was changed after the results of ESPAC-4 trial. 19 SPSS software (version 20) was used for statistical analysis of the data. Mean ± standard deviation was determined for continuous variables while frequencies and percentages were determined for categorical variables. The Kaplan-Meier method estimated survival as a function of time; and survival differences were analysed by either Log-Rank test or Tarone-Ware test. Statistical significance was defined as a two-tailed p-value 0.05.
RESULTS
In our study, 101 patients underwent pancreatico-duodenectomy in three years. Among them, 57.4% (n=58) were males and 42.4% (n=43) were females. The commonly found tumor was periampullary tumor, which was present in 49.5% (n=50) patients followed by pancreatic head adenocarcinoma, which was present in 32.7% (n=33) patients; and 17.8% (n=18) patients had other tumors. Mean age was 51.5 ±14.17 years. The most common pathological T-stage was T3 present in 47.5% (n=48) patients, followed by T2 found in 36.6% (n=37) patients, and T1 stage was present in 15.8% (n=16) patients. Nodal involvement was seen in 57.4% (n=58) patients (Table I) .
Pancreaticogastrostomy was performed in 87.13% (n=88) patients, while PJ was performed in 12.87% (n=13) patients. Recurrence was observed in 11.9% (n=12) patients, while 88.1% (n=89) patients had no recurrence. Mean survival of pancreatic tumors was 787.04 ±81.89 days, while the mean survival of periampullary tumors was 983.10 ±52.27 days (p=0.08). Overall mean survival was 924 ±41.3 days ( Figure 1A) . Disease-free survival of patients with periampullary tumor was better than patients with pancreatic head tumor ( Figure 1B) . Estimated three years survival of T1 and T2 tumors was about 85%, while T3 tumor had estimated survival of 40% at three years (Figure 2A) . Similarly, T1 and T2 tumors had better disease-free survival than T3 tumors ( Figure 2B ). Overall estimated survival of node negative disease was about 85% while node positive disease had about 50% survival ( Figure 2C ). Patients with node negative disease had better disease free survival than patients who had node positive disease ( Figure 2D ). (Table II) . Type A fistula was observed in 14 (13.9%) patients. Eight (7.9%) patients developed type B fistula, while type C fistula was seen in 5 (5%) patients. There was one death recorded within 30 days of postoperative period.
POPF was noted in 27 patients

DISCUSSION
Despite advancements in the perioperative care, pancreaticoduodenectomy is associated with high morbidity and mortality that is about >50% and 2%, respectively. 20 But with recent advancement in surgical technique, better understanding of disease process and critical care, this procedure is adopted worldwide for the treatment of pancreatic head and periampullary neoplasms.
Large tumor size and old age are no more contraindications of surgery. Even in elderly population, survival benefit is same after resection. The results are comparable with published international literatures in terms of 30 days mortality and morbidity. 21 A lot of work has been done in the last two decades to reduce frequency of POPF, including different techniques of pancreatic anastomosis like PG, PJ, duct to mucosa and invagination technique. Although, no consensus has been made about the best technique, but some studies have shown that PG is better than PJ. [22] [23] [24] Apart from surgical technique, texture of pancreas is also a contributing factor in terms of developing POPF. Studies have shown that non-dilated pancreatic duct and soft pancreas are associated with higher chances of POPF. 13, 25 Portal vein or SMV involvement by the tumor is no more a contraindication to surgery. Perioperative morbidity and survival after venous resection and reconstruction have been found to be comparable to standard resection. 25 Vascular anomalies should be identified preoperatively with a tri-phasic CT scan to avoid any inadvertent injury to hepatic arteries.
Achieving a low morbidity and mortality rate after surgery is a function of individual surgeon's experience as well as the volume of institution. High volume centres tend to have more surgeons specialising in specific procedures, more consistent postoperative care, betterstaffed ICUs, and greater resources to deal with postoperative complications.
Patient's selection as well as preoperative evaluation and optimisation, surgical technique and postoperative care are extremely significant not only in reducing patient's mortality and morbidity but also for long term oncological outcome. A dedicated hepato-pancreatobiliaray unit and a reasonable level of experience along with multidisciplinary treatment approach is thus necessary to achieve such good results.
Despite advancement in chemotherapeutic regimens, surgical resection still remains mainstay of treatment for pancreatic head and periampullary neoplasms. This study shows that early tumor stage, absence of metastases to lymph nodes and periampullary tumor site are strong prognostic indicators for patient survival after pancreaticoduodenectomy. Pancreaticogastrostomy was the preferred technique of reconstruction in this study. POPF rate and perioperative mortality is comparable with international published data. Hence, this technique of reconstruction is a safe alternative to pancreaticojejunostomy after pancreaticoduodenectomy.
The new finding in this study is that three years survival of periampullary tumors was much better than pancreatic head tumors. When compared with international literature, periampullary tumor has better survival rate. The survival of pancreatic head tumor is comparable with published data. 20 Currently, there is no prognostic tool to predict survival according to these neoplasms originating from different sites. Further studies can be done focusing on tumor biology and the site of tumor with its impact on patient's overall and disease-free survival. This can also lead to separate perioperative treatment strategies according to specific tumor biology and site of the disease.
This study has its limitations. First of all, this is a retrospective study. There is no comparison of choice of procedure. The follow-up is of short duration. There needs to be a follow-up study, which can focus on 5 years overall and disease-free survival.
